Edick Paul R

Director at Vistagen Therapeutics, Inc. · on record since Nov 4, 2025
Director at Sucampo Pharmaceuticals, Inc. · on record since Aug 9, 2016
Director at LUMOS PHARMA, INC. · on record since Nov 14, 2011
Director at Durata Therapeutics, Inc. · on record since Jul 26, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 18, 2012
Chief Executive Officer at Durata Therapeutics, Inc. · on record since Feb 14, 2013
Director at Neos Therapeutics, Inc. · on record since Jul 22, 2015
Director at PDL BIOPHARMA, INC. · on record since Sep 8, 2015
Director at Iterum Therapeutics plc · on record since May 30, 2018
Director at XERIS PHARMACEUTICALS INC · on record since Jun 27, 2018
Director at Milestone Pharmaceuticals Inc. · on record since May 8, 2019
See Remarks at XERIS PHARMACEUTICALS INC · on record since Jun 27, 2018

Insider trading activity of Edick Paul R

Transactions on record: 94; since Nov 14, 2011

Open-market buys: 16; $1.6M

Open-market sells: 0

Companies traded: 10; last filing Nov 4, 2025

Figures computed from official regulatory filings — .

Companies where Edick Paul R has traded

Vistagen Therapeutics, Inc.1 tx · Nov 4, 2025
Xeris Biopharma Holdings, Inc.17 tx · $654.4K · Jan 31, 2024
XERIS PHARMACEUTICALS INC21 tx · $712K · Oct 5, 2021
Milestone Pharmaceuticals Inc.1 tx · Jun 8, 2020
10 tx · $5.2K · May 29, 2019
4 tx · $700K · Jun 12, 2018
7 tx · $345.7K · Feb 13, 2018
2 tx · Jul 5, 2017
14 tx · May 16, 2017
17 tx · $1M · Nov 18, 2014

Track record of Edick Paul R

Statistical track record

Free account

Open-market buys: 17

Last buy: Aug 9, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Edick Paul R

Co-insiders of Edick Paul R

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Vistagen Therapeutics, Inc.Listing on record	Nov 4, 2025	AwardD (derivative)	35,200	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 31, 2024	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 31, 2024	Award	1,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Aug 9, 2023	Buy	10,000	2.38 USD	$23.8K	conv 25	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Feb 1, 2023	Award	750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Dec 14, 2022	Buy	20,000	1.45 USD	$29K	conv 11	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	May 13, 2022	Buy	100,000	1.40 USD	$140K	conv 16	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 5, 2022	Award	600,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Nov 16, 2021	Buy	20,000	2.28 USD	$45.6K	conv 54Cluster	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Nov 12, 2021	Buy	200,000	2.08 USD	$416K	conv 68ClusterUnusual size	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	197,231	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	668,065	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	410,833	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	400,000	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-200,000	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-69,822	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-197,231	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-400,000	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	69,822	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-668,065	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-410,833	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-13,430	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	98,252	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-98,252	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	13,430	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Vistagen Therapeutics, Inc.Listing on record	Nov 4, 2025	AwardD (derivative)	35,200	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 31, 2024	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 31, 2024	Award	1,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Aug 9, 2023	Buy	10,000	2.38 USD	$23.8K	conv 25	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Feb 1, 2023	Award	750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Dec 14, 2022	Buy	20,000	1.45 USD	$29K	conv 11	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	May 13, 2022	Buy	100,000	1.40 USD	$140K	conv 16	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jan 5, 2022	Award	600,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Nov 16, 2021	Buy	20,000	2.28 USD	$45.6K	conv 54Cluster	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Nov 12, 2021	Buy	200,000	2.08 USD	$416K	conv 68ClusterUnusual size	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	197,231	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	668,065	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	410,833	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	400,000	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-200,000	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-69,822	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-197,231	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-400,000	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	69,822	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-668,065	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-410,833	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	Other	-13,430	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	AwardD (derivative)	98,252	—	n/a (No price was disclosed in the filing)		SEC
XERIS PHARMACEUTICALS INCListing on record	Oct 5, 2021	OtherD (derivative)	-98,252	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Oct 5, 2021	Award	13,430	—	n/a (No price was disclosed in the filing)		SEC